We are live on ! Find out more
RCM

Revelation Capital Management Portfolio holdings

AUM $67.4M
This Fund
S&P 500
This Quarter Est. Return
-40.62%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.07M
AUM Growth
-$20.3M
Cap. Flow
-$13.7M
Cap. Flow %
-194.26%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
ACCD
Accolade Inc
ACCD
+$508K

Top Sells

Rank Stock Value
1
ME
23andMe Holding Co
ME
+$10.2M
2
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
+$3.14M
3
NPCE icon
Neuropace
NPCE
+$876K

Sector Composition

Rank Sector Weight
1 Healthcare 93.92%
2 Industrials 6.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMIC
1
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$5.41M 76.54%
47,195
-26,803
-36% -$3.14M
NPCE icon
2
Neuropace
NPCE
$522M
$1.23M 17.38%
248,127
-132,578
-35% -$876K
ACCD
3
DELISTED
Accolade Inc
ACCD
$430K 6.08%
+58,050
New +$508K
ME
4
DELISTED
23andMe Holding Co
ME
– –
-133,387
Closed -$10.2M

Similar funds

RC
Rithm Capital New York $67.4M AUM 37.43% 1-Year Est. Return
MA
Mosaic Advisors Houston, Texas $66.8M AUM 23.34% 1-Year Est. Return
S4W
Solutions 4 Wealth Southlake, Texas $66.5M AUM 10.15% 1-Year Est. Return
SGOM
SIP Global Opportunity Manager Portsmouth, New Hampshire $66.3M AUM
VIM
VCU Investment Management Richmond, Virginia $68.6M AUM
ILCM
Ivy Lane Capital Management Winter Park, Florida $66.1M AUM 28.52% 1-Year Est. Return
FWA
Fidelis Wealth Advisors Castle Rock, Colorado $68.7M AUM
EVC
Emeth Value Capital New Orleans, Louisiana $66M AUM 35.55% 1-Year Est. Return

Revelation Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Revelation Capital Management held 4 positions worth $7.07M, down 74% from $27.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Revelation Capital Management withdrew a net $13.7M in Q2 2022, closing 1 position and reducing 2 holdings. Its most notable exit was 23andMe Holding Co, an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 100% a quarter earlier, followed by Industrials.

Against the trend, Revelation Capital Management opened a new position in Accolade Inc worth $430K.

  • Revelation Capital Management's largest Q2 2022 buy was Accolade Inc: 58,050 shares worth $430K.
  • Revelation Capital Management's biggest Q2 2022 reduction was Singular Genomics Systems, Inc. Common Stock, cutting an estimated $3.14M.
  • Revelation Capital Management fully exited 23andMe Holding Co in Q2 2022, selling an estimated $10.2M.
  • Revelation Capital Management's ten largest holdings make up 100% of its $7.07M portfolio in Q2 2022.
  • Revelation Capital Management opened 1 new position and closed 1 in Q2 2022.
  • Revelation Capital Management's portfolio value fell 74% quarter-over-quarter to $7.07M.

Based on Revelation Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.